Arie Belldegrun - Mar 26, 2021 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Mar 26, 2021
Transactions value $
$16,205
Form type
4/A - Amendment
Date filed
6/9/2021, 01:47 PM
Date Of Original Report
Apr 22, 2021
Next filing
May 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $16.2K +3.24K +1.34% $5.00 245K Mar 26, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -3.24K -100% $0.00* 0 Mar 26, 2021 Ordinary Shares 3.24K $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021.